These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27665853)

  • 1. Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.
    Jung JH; Song GG; Kim JH; Seo YH; Choi SJ
    Cardiol J; 2017; 24(1):74-84. PubMed ID: 27665853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
    Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.
    Guodong Jin ; Beili Feng ; Peng Chen ; Oushan Tang ; Jian Wang ; Ji Ma ; Yuping Shi ; Geng Xu
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):208-13. PubMed ID: 20211923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis.
    Chen F; Qiao Q; Xu P; Fan B; Chen Z
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):783-92. PubMed ID: 24042156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.
    Vokó Z; Bereczky Z; Katona E; Adány R; Muszbek L
    Thromb Haemost; 2007 Mar; 97(3):458-63. PubMed ID: 17334514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
    Kreutz RP; Bitar A; Owens J; Desta Z; Breall JA; von der Lohe E; Sinha A; Vatta M; Nystrom P; Jin Y; Flockhart DA
    J Thromb Thrombolysis; 2014 Oct; 38(3):380-7. PubMed ID: 24510702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the F13A1 Val34Leu polymorphism and recurrent pregnancy loss: A meta-analysis.
    Jung JH; Kim JH; Song GG; Choi SJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():234-240. PubMed ID: 28683377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.
    Boekholdt SM; Sandhu MS; Wareham NJ; Luben R; Reitsma PH; Khaw KT
    J Thromb Haemost; 2006 Oct; 4(10):2204-9. PubMed ID: 16881935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
    Mills JD; Mansfield MW; Grant PJ
    Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.
    Bronić A; Ferencak G; Zadro R; Stavljenić-Rukavina A; Bernat R
    Mol Biol Rep; 2009 Jan; 36(1):1-5. PubMed ID: 17899444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
    Weger M; Renner W; Stanger O; Schmut O; Deutschmann H; Wascher TC; Haas A
    Stroke; 2001 Dec; 32(12):2759-61. PubMed ID: 11739969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
    Warner D; Mansfield MW; Grant PJ
    Thromb Haemost; 2001 Mar; 85(3):408-11. PubMed ID: 11307805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis.
    Han H; Wang H; Yin Z; Jiang H; Fang M; Han J
    Gene; 2013 Sep; 526(2):134-41. PubMed ID: 23685282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
    Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype--phenotype case control study.
    Silvain J; Pena A; Vignalou JB; Hulot JS; Galier S; Cayla G; Bellemain-Appaix A; Barthélémy O; Beygui F; Bal-dit-Sollier C; Drouet L; Weisel JW; Montalescot G; Collet JP
    Thromb Haemost; 2011 Sep; 106(3):511-20. PubMed ID: 21800001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.